The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Levocetirizine dihydrochloride 5 mg Film-Coated Tablets

Brillpharma (Ireland) LimitedPA22749/003/001

Main Information

Trade NameLevocetirizine dihydrochloride 5 mg Film-Coated Tablets
Active SubstancesLevocetirizine dihydrochloride
Dosage FormFilm-coated tablet
Licence HolderBrillpharma (Ireland) Limited
Licence NumberPA22749/003/001

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE09 levocetirizine


License statusAuthorised
Licence Issued07/09/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0095-001-003
Interchangeable List DocumentPDF of Interchangeable List
« Back